1832 Asset Management L.P. Tandem Diabetes Care Inc Transaction History

1832 Asset Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $10.2 Million - $15 Million	-99,800 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$118.18 - $153.21 $4.7 Million - $6.1 Million	39,800 Added 66.33%	99,800 $15.3 Million
Q3 2021 Nov 15, 2021	BUY	$93.51 - $129.4 $5.61 Million - $7.76 Million	60,000 New	60,000 $7.24 Million
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $3.61 Million - $5.09 Million	-41,800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $3.99 Million - $4.85 Million	41,800 New	41,800 $4.74 Million
Q2 2019 Aug 14, 2019	SELL	$54.41 - $71.7 $8.06 Million - $10.6 Million	-148,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $4.78 Million - $10.9 Million	148,100 New	148,100 $9.3 Million

352

73M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.38B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.